Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arkell

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Development (Cambridge, England)|January 1, 1997
BMP-7 influences pattern and growth of the developing hindbrain of mouse embryosR Arkell, R S Beddington
Australian Journal of General Practice|June 1, 2021
Medical cannabis and drivingThomas R Arkell, Danielle McCartney, Iain S McGregor
Neuroscience and Biobehavioral Reviews|January 26, 2021
Determining the magnitude and duration of acute Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC)-induced driving and cognitive impairment: A systematic and meta-analytic reviewDanielle McCartney, Thomas R Arkell, Christopher Irwin, et al.
Journal of Psychopharmacology (Oxford, England)|February 9, 2024
A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performanceBrooke Manning, Thomas R Arkell, Amie C Hayley, et al.
Development (Cambridge, England)|April 1, 1994
Expression of inhibin subunits and follistatin during postimplantation mouse development: decidual expression of activin and expression of follistatin in primitive streak, somites and hindbrainR M Albano, R Arkell, R S Beddington, et al.
CNS Drugs|November 9, 2023
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive PerformanceThomas R Arkell, Brooke Manning, Luke A Downey, et al.
Addiction Biology|March 1, 2022
Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trialsThomas R Arkell, Kristina Bradshaw, Luke A Downey, et al.
JAMA Network Open|May 9, 2023
Assessment of Medical Cannabis and Health-Related Quality of LifeThomas R Arkell, Luke A Downey, Amie C Hayley, et al.
Neuroscience and Biobehavioral Reviews|November 12, 2021
Are blood and oral fluid Δ<sup>9</sup>-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysisDanielle McCartney, Thomas R Arkell, Christopher Irwin, et al.
Traffic Injury Prevention|February 5, 2021
The failings of <i>per se</i> limits to detect cannabis-induced driving impairment: Results from a simulated driving studyThomas R Arkell, Tory R Spindle, Richard C Kevin, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Development (Cambridge, England)|January 1, 1997
BMP-7 influences pattern and growth of the developing hindbrain of mouse embryosR Arkell, R S Beddington
Australian Journal of General Practice|June 1, 2021
Medical cannabis and drivingThomas R Arkell, Danielle McCartney, Iain S McGregor
Neuroscience and Biobehavioral Reviews|January 26, 2021
Determining the magnitude and duration of acute Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC)-induced driving and cognitive impairment: A systematic and meta-analytic reviewDanielle McCartney, Thomas R Arkell, Christopher Irwin, et al.
Journal of Psychopharmacology (Oxford, England)|February 9, 2024
A semi-naturalistic open-label study examining the effect of prescribed medical cannabis use on simulated driving performanceBrooke Manning, Thomas R Arkell, Amie C Hayley, et al.
Development (Cambridge, England)|April 1, 1994
Expression of inhibin subunits and follistatin during postimplantation mouse development: decidual expression of activin and expression of follistatin in primitive streak, somites and hindbrainR M Albano, R Arkell, R S Beddington, et al.
CNS Drugs|November 9, 2023
A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive PerformanceThomas R Arkell, Brooke Manning, Luke A Downey, et al.
Addiction Biology|March 1, 2022
Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trialsThomas R Arkell, Kristina Bradshaw, Luke A Downey, et al.
JAMA Network Open|May 9, 2023
Assessment of Medical Cannabis and Health-Related Quality of LifeThomas R Arkell, Luke A Downey, Amie C Hayley, et al.
Neuroscience and Biobehavioral Reviews|November 12, 2021
Are blood and oral fluid Δ<sup>9</sup>-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysisDanielle McCartney, Thomas R Arkell, Christopher Irwin, et al.
Traffic Injury Prevention|February 5, 2021
The failings of <i>per se</i> limits to detect cannabis-induced driving impairment: Results from a simulated driving studyThomas R Arkell, Tory R Spindle, Richard C Kevin, et al.
Pageof 4